8 Ways to Create Value in Cancer Care

Slideshow

This slide show features 8 ways oncologists can create value in cancer care, from building a great team of staff members to staying on top of the latest developments in your field.

References:

1. Krasner MS; Epstein RM, Beckman H, et al. Association of an educational program in mindful communication with burnout, empathy, and attitudes among primary care physicians. JAMA. 2009;302:1284-93.Read here.

Recent Videos
Beta emitters like 177Lu-rosopatamab may offer built-in PSMA imaging during the treatment of patients with metastatic castration-resistant prostate cancer.
Ongoing ctDNA analysis may elucidate outcomes associated with divarasib plus migoprotafib for those with KRAS G12C–positive NSCLC.
2 experts are featured in this series.
2 experts are featured in this series.
4 experts in this video
Related Content
Support for the decision follows a positive opinion from the Committee for Medicinal Products for Human Use based on the phase 3 ECHO trial results.

Acalabrutinib Combo Receives EU Approval for Mantle Cell Lymphoma

Roman Fabbricatore
May 6th 2025
Article

Support for the decision follows a positive opinion from the Committee for Medicinal Products for Human Use based on the phase 3 ECHO trial results.

Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia

Nora M. Gibson, MD, MSCE;Taha Al-Juhaishi, MD
May 5th 2025
Podcast

Therapies like betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.

Neurovascular Sparing during Radiation Reduces Incidence of ED in Prostate Cancer

Neurovascular Sparing during Radiation Reduces Incidence of ED in Prostate Cancer

Tim Cortese
May 6th 2025
Article

The 1.5T Elekta Unity MR-Linac demonstrated lower rates of erectile dysfunction with neurovascular sparing vs without in patients with intermediate-risk prostate cancer.

Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer

Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer

Manojkumar Bupathi, MD, MS;Manojkumar Bupathi, MD, MS
May 1st 2025
Podcast

Oncology Decoded hosts discuss adjuvant therapy in kidney cancer, including research, treatment strategies, and management of recurrence.

HITOCH After Surgery Appears Safe, May Improve Survival in Mesothelioma

HITOCH After Surgery Appears Safe, May Improve Survival in Mesothelioma

Tim Cortese
May 6th 2025
Article

A systematic review shows that patients with mesothelioma who received HITOCH experienced between 13 to 35 months of survival.

“The findings show that access to clinical trials alone is insufficient to overcome the inferior survival outcomes experienced by Black and Hispanic children with cancer,” according to lead study author Puja Umaretiya, MD, MS.

Data Show Racial/Ethnic Disparities in Pediatric Brain Cancer Survival

Russ Conroy
May 5th 2025
Article

Clinical trial access alone appears to be insufficient in overcoming the worse survival outcomes observed in Black and Hispanic pediatric populations.